Medicinal Chemistry in Europe II
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 14646
Special Issue Editors
2. Department of Chemical Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 78371 Olomouc, Czech Republic
Interests: medicinal chemistry; drug design; structure–activity relationships; pharmaceutical analysis; polymorphism; drug bioavailability; ADME; nanoparticles; nanoformulations; controlled/targeted delivery
Special Issues, Collections and Topics in MDPI journals
Interests: quinoline chemistry and applications; anticancer agents; antifungals; drug design
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Medicinal chemistry uses physical, chemical, biochemical, molecular biological, immunological, genetic, and computer technology methods, the versatile understanding of which contributes to progress in the research, manufacturing, evaluation, and control of chemical drugs/pharmaceutics. It is evident that medicinal (or pharmaceutical) chemistry is an interdisciplinary branch that has its “roots“ in all chemical and biological sciences; nevertheless, the unique area of its interests lies in the search of structure–activity relationships (relationships between the chemical structure and the biological effect of potential drugs). Thus, medicinal chemistry is focused on the study of essential knowledge and explanation of the mechanism of action, structure–activity relationships, biodynamic behavior, and chemical reactivity of drugs. Since its beginnings, from Paracelsus (1493–1541), the father of chemiatria, over chemical laboratories in apothecaries of the 18th and 19th centuries, to these days, medicinal chemistry has come a long way. Thus, although inspiration is still derived from nature (secondary metabolites) with the new millennium in the design of new drugs, it is possible to trace the effort to develop drugs “designed” based on the precise knowledge of structural biology (genomics) and other molecular–biological–chemical sciences. With respect to the abovementioned facts, this Special Issue of Molecules titled “Medicinal Chemistry in Europe II” is devoted to the following research topics focused on all fields of medicinal chemistry: (i) drug design; (ii) natural compounds; (iii) synthesis and analysis; (iv) study of physicochemical parameters of drugs; (v) in silico investigations; (vi) biological screening; (vii) chemical biology and biological chemistry; (vii) biomaterials; (viii) excipients; and (ix) diagnostics, and in general, other topics related to design, discovery, research, and development of biologically active agents.
Prof. Dr. Josef Jampilek
Dr. Robert Musiol
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Medicinal chemistry
- Drug design
- Chemical biology
- Biological chemistry
- Pharmacophore
- Computer study
- Modeling
- Docking
- Structure–activity relationships
- Synthesis
- Analysis
- Natural compounds
- Physicochemical properties
- ADMET
- Biological screening
- Drugs
- Diagnostics
- Excipients
- Biomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.